Is RXRX stock safe? | Glauxie AI

Q: Is RXRX stock safe?

Recursion Pharmaceuticals, Inc. (RXRX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Najat Khan. Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation,... Employees: 200,000.

Q: What are the risks of investing in RXRX?

Identify key risks of investing in RXRX — debt, competition, volatility, and sector headwinds.

Q: Is RXRX a good long-term investment?

Evaluate RXRX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does RXRX have?

Review RXRX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is RXRX stock safe?

🦉

Recursion Pharmaceuticals, Inc. (RXRX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEONajat Khan

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is...

Key Executives

Name	Title
Ben R. Taylor	Chief Financial Officer & President of Recursion UK
Benjamin Mabey	Chief Technology Officer
Christopher C. Gibson	Co-Founder, Chairman & Interim Executive Advisor
David Hallett	Chief Scientific Officer
David J. Mauro	Advisor
Elizabeth Bruckheimer	Vice President of Clinical Development

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

RXRX Profile Financials

What are the risks of investing in RXRX? Is RXRX a good long-term investment? How much debt does RXRX have?